DIABETES management

 

MLD improves artery/vessel integrity and reduces inflammation


Etiology

Diabetes is a group of diseases characterized by high blood glucose levels that result from defects in the body's ability to produce and/or use insulin. Diabetes leads to arterial insufficiency, diabetic neuropathies and poor wound and tissue healing.​


The multi-systemic impacts and risks of diabetes are far ranging. Those relative to MLD therapy include:

  • Haemorheological disturbances that can alter arterial flow resulting in chronic tissue hypoxia
  • Chronic venous insufficiency
  • A strong association between diabetes and peripheral arterial occlusive disease (PAOD), with macro and micro-circulatory impairment
  • Macrovascular disease, in diabetic patients is due to the same atherosclerotic changes observed in the non-diabetic population; however, PAOD tends to occur at a younger age and is more aggressive
  • Peripheral arterial disease (ischaemia) is rarely a causative factor for diabetic foot ulcers, but rather an underlying aetiology that impedes wound healing



MLD Treatment Protocols

  • Edema reduction phase, typically 1 to 3 weeks
  • MLD therapy with combined decongestive therapy (CDT)
  • Compression bandaging is worn through the day and removed before sleep
  • Compression bandaging can be safely applied over wound care dressings
  • Wound care performed by the patient or a qualified medical professional (but not the MLD therapist)
  • Ulcers generally close after 2 to 4 weeks of MLD therapy. They do not re-open with regular maintenance
  • MLD therapy maintenance visits (once every 6 weeks) and daily wearing of compression garments (without exception).

MLD CLINIC   237 PURCELLS COVE ROAD, HALIFAX, NS  (902) 448 0940

​​MLD  CLINIC

MANUAL LYMPHATIC DRAINAGE THERAPY